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IL-5-Deficient Mice Have a Developmental Defect
in CD5+ B-1 Cells and Lack Eosinophilia but Have
Normal Antibody and Cytotoxic T Cell Responses
Manfred Kopf,1, 6 Frank Brombacher,1 considerable interest in defining the biological role of
IL-5, the cytokine which appears to most specificallyPhilip D. Hodgkin,2 Alistair J Ramsay,2
Elizabeth A. Milbourne,4 Wen J. Dai,1 regulate the eosinophil lineage (Coffman et al., 1989a;
Sanderson, 1992).Karen S. Ovington,4 Carolyn A. Behm,4
Georges KoÈ hler,1, 5 Ian G. Young,3 Although much progress has been made on the biol-
ogy of IL-5 (for review see Sanderson, 1994), there areand Klaus I. Matthaei3
1Max Planck Institut fuÈ r Immunbiologie still uncertainties concerning its role in vivo. While
transgenic mice expressing IL-5 under a metallothioneinStuÈ beweg 51
D-79108 Freiburg promoter have an increase in number of CD5+ (B-1) B
cells, elevated IgM levels and develop autoimmunityFederal Republic of Germany
2Division of Cell Biology (Tominaga et al., 1991), no effects on B cells or antibody
levels were found in transgenic mice expressing IL-53Division of Biochemistry and Molecular Biology
The John Curtin School of Medical Research under the control of the CD2 locus control region (Dent
et al., 1990; Sanderson et al., 1993). Both transgenic4Division of Biochemistry and Molecular Biology
The Faculties lines, however, develop persistent eosinophilia (Dent et
al., 1990; Tominaga et al., 1991).The Australian National University
Canberra ACT Specific ligand binding receptors for IL-5, IL-3, and
GM±CSF consisting of an a chain for low affinity interac-Australia, 0200
tion have been shown to assemble with a common b
chain to each receptor to form high affinity ab receptor
complexes (Miyajima et al., 1993). This may explain whySummary
these cytokines exert overlapping activities on different
cell types in vitro, such as promoting the generation ofMice deficient in interleukin-5 (IL-52/2 mice) were gen-
erated by gene targeting in embryonal stem cells. Con- eosinophils from hematopoietic precursors (Miyajima et
al., 1993, Warren and Moore, 1988). So far, it remainstrary to previous studies, no obligatory role for IL-5
was demonstrated in the regulation of conventional B unclear to what extent these cytokines are functionally
redundant in an organism.(B-2) cells, in normal T cell±dependent antibody re-
sponses or in cytotoxic T cell development. However, Further detailed investigations of the biological roles
of IL-5 for B cell development and function, and theCD5+ B cells (B-1 cells) in the peritoneal cavity were
reduced by 50%±80% in 2-week-old IL-52/2 mice, re- contribution of eosinophils to the pathogenesis of
asthma and to host resistance to parasites would beturning to normal by 6±8 weeks of age. The IL-52/2
mice did not develop blood and tissue eosinophilia greatly facilitated by the generation of an IL-52/2 mouse.
In the present work, we report the generation of such awhen infected with the helminth Mesocestoides corti,
but basal levels of eosinophils with normal morpholgy mouse. The role of IL-5 in the regulation of systemic
and local antibody production,antiviral killer cell activity,were produced in the absence of IL-5. IL-5 deficiency
did not affect the worm burden of infected mice, indi- peritoneal CD5+ B-1 cells, and eosinophils is investi-
gated. It is clear from the present studies that the IL-cating that increased eosinophils do not play a signifi-
cant role in the host defence in this parasite model. 52/2 mouse will also be extremely valuable in further
definition of the biological roles of IL-5 and eosinophils
in host defence, bronchoconstriction, and allergic in-
flammation.Introduction
Interleukin-5 (IL-5) is a homodimeric glycoprotein en- Results
coded on mouse chromosome 11 and human chromo-
The Generation of Mice Homozygous for asome 5 in a cluster containing the genes for IL-3, IL-4,
Mutation in the IL-5 GeneIL-13, and granulocyte±macrophage colony-stimulating
Homologous recombination in C57BL/6 embryonic stemfactor (GM±CSF) (Boulay and Paul, 1992). IL-5 is pro-
(ES) cells (Ledermann and Burki, 1991) was used toduced mainly by activated T lymphocytes and was origi-
generate a C57BL/6 mouse strain lacking IL-5 usingnally recognized by its activity as a B cell growth factor
conventional gene targeting techniques (Thomas and(Kinashi et al., 1986), an immunoglobulin A (IgA)-enhanc-
Capecchi, 1987). The procedures aresummarized in Fig-ing factor (Yokota et al., 1987), and as a differentiation
ure 1 (A, B, C). In brief, the neomycin resistance genefactor for the eosinophil lineage (Campbell et al., 1987,
(neor) was inserted into exon 3 of the IL-5 gene in a1988). The involvement of eosinophils in allergic dis-
codon for one of the cysteine residues required for IL-eases such as asthma (Corrigan and Kay, 1992) and in
5 activity (Campbell et al., 1988; Takahashi et al., 1990).parasitic infections (Finkelman et al., 1991) has created
The altered gene was incorporated into a targeting vec-
tor and electroporated into ES cells. Homologous re-5Georges KoÈ hler died during the preparation of this manuscript.
combinants were identified by positive±negative selec-6Present address: Basel Institute for Immunology, Grenzacher-
strasse 487, 4005 Basel, Switzerland. tion (Mansour et al., 1988) and a polymerase chain
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Figure 1. Targeted Disruption of the IL-5
Gene
(A) Schematic structure of the targeting vec-
tor pmIL-5±neo±tk.
(B) Genomic structure of the IL-5 gene. The
coding regions of exons numbered 1±4 are
represented by boxes and relevant restriction
sites are indicated.
(C) The predicted structure of the mutated IL-
5 allele following homologous recombination.
The location of PCR primers used for the de-
tection of homologous recombinants is indi-
cated.
reaction (PCR) based strategy using nested primers indicating normal B cell development. Mature T cell help
and conventional B cell function were studied by immu-(Nitschke et al., 1993). Verification of the targeting was
made by Southern blot analysis of genomic DNA from nization with dinitrophenylated ovalbumin (DNP±ova). In
mutant mice, both primary and secondary T cell±selected ES cells and the targeted clones shown to have
incorporated only one neor gene. Following injection of dependent immunoglobulin responses were compara-
ble to those in IL-5+/+ controls (Figure 3A).homologous recombinants into blastocysts, chimeras
were obtained able to transmit the mutated allele Specific immunoglobulin responses were also mea-
sured following intranasal infection of the respiratorythrough the germline. Heterozygous mice were crossed
to obtain mice homozygous for the targeted IL-5 gene. tract with influenza virus. This normally results in local
antiviral responses, predominantly of the IgA and IgGThe IL-5 mutation was inherited at the expected fre-
quency and the animals remained healthy and fertile subclasses (Jones and Ada, 1986). The numbers of spe-
cific IgA-producing B cells at day 8 and 15 were unaf-throughout 1 year of observation under specific patho-
gen-free conditions. fected in IL-52/2 mice as compared with controls, as
were those of IgM-, IgG1-, and IgG2a-producing B cellsTo verify the IL-5 deficiency, T cell±enriched spleen
cells were stimulated in vitro under conditions that pro- (Figures 4A, 4B). Serum antibody levels were also similar
in IL-52/2 and control mice (data not shown).mote the development of T helper 2 (Th2) cells express-
ing IL-4 and other related cytokines, such as IL-5 and From the above results we conclude that IL-5 plays
no obligatory role in Th-dependent B cell responsesIL-10. Reverse transcriptase (RT)±PCR analysis of the
stimulated cells showed a defect in the production of both after systemic and mucosal challenge. This conclu-
sion contrasts with the first reported activity of IL-5 andIL-5 mRNA in the mutant mice but normal expression
of IL-3 and IL-4 mRNA (Figure 2A). Similarly, IL-5 was other studies that have suggested a role for IL-5 in this
process (Beagley et al., 1988; Kinashi et al., 1986; Murrayundetectable by enzyme-linked immunosorbent assay
(ELISA) in the supernatants of the stimulated cells, et al., 1987).
Cytotoxic T lymphocyte (CTL) and natural killer (NK)whereas levels of the cytokines IL-2, IL-3, IL-4, IL-10,
and interferon-g (IFNg) were normal (Figure 2B). The cell activity in mutant and control mice were compared
in the light of reports that IL-5 has ªkiller±helperº activityeffect on IL-5 levels is therefore specific with no indica-
tion of effects on the generation of Th1 or Th2 cytokines. and promotes the expression of high affinity IL-2 recep-
tors and the generation of CTL in thymocyte populationsThis contrasts with the results previously obtained with
IL-4-deficient mice that have an altered CD4+ T cell sub- in vitro (Takatsu et al., 1987). In mice infected with vac-
cinia virus, neither the generation of antiviral CTL andset development and, as a consequence, indirect effects
on Th1 and Th2 cytokine production including IL-5 (Kopf NK responses, nor the rate of clearance of virus, which
reflects the activity of these cell populations, were af-et al., 1993).
fected by IL-5 deficiency (Figures 5A, 5B, 5C). Similar
results were found using mice infected with influenza
B and T Lymphocyte and Natural Killer Cell virus (data not shown). We conclude that IL-5 does not
Responses in IL-52/2 Mice play a crucial role in the development of antiviral killer
Cytofluorometric analysis showed normal numbers of B cell activity.
and T cells in bone marrow, spleen, and thymus of adult
IL-52/2 mice as compared with age-matched controls.
Thymocytes and peripheral T cells had normal expres- Peritoneal B1 Cells in IL-52/2 Mice
Peritoneal B-1a and B-1b cells were characterized assion patterns of T cell receptor a, b, g, d chains, CD44,
CD24, CD4, and CD8. The expression of B220, IgM, IgD, cells that are CD5+ or CD52, respectively, B220lo, IgMhi,
IgDlo, CD232, and Mac-1+ (Kantor et al., 1992; FiguresCD23, CD24, and CD43 on preB and conventionalB (B-2)
cells in the bone marrow and spleen was also unaltered 6A±6C; IgD, B220, and CD23 data not shown). This dis-
tinguishes them from B-2 cells that are CD52, B220hi,(data not shown).
Natural serum immunoglobulin levels of naive IL-52/2 IgMlo, IgDhi, CD23+, and Mac-12. The CD52 B-1b sister
population (Kantor et al., 1992) seems not to be affectedand control mice were not significantly different, further
Phenotype of IL-5-Deficient Mice
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Figure 2. Cytokine Profile of the Mutant Mouse
(A) RT±PCR analysis of IL-3, IL-4, and IL-5. B cell± and red cell±depleted spleen cells were stimulated in anti-CD3-coated wells in the presence
of recombinant murine IL-4 for 4 days, washed and cultured for a further 2 days in medium containing IL-2, and then restimulated for 16 hr
in anti-CD3-coated wells together with anti-CD28. RNA was extracted and RT±PCR performed as described in Experimental Procedures. PCR
products were separated on an agarose gel stained with ethidium bromide. M, DNA molecular weight marker; C, reagent control.
(B) Analysis of cytokines by ELISA. B cell± and red cell±depleted spleen cells were stimulated as above and cytokines were measured in cell
supernatants by ELISA as described in Experimental Procedures. The lower limit of detection for each cytokine is indicated by the broken
line.
in IL-52/2 mice, although in 1 of 3 experiments we noticed the metacestode parasite Mesocestoides corti. Intra-
peritoneal injection of the tetrathyridial (larval) stage ofa 40% reduction (Table 1). In 2-week-old IL-52/2 mice,
the numbers of CD5+ B (B-1a) cells were reduced by M. corti results in a chronic infection in mice. Larvae
migrate to the liver, where they multiply asexually. Infec-50%±80% as compared with controls (Figure 6C; Table
1). B-1a cells can be separated into IgMlo cells (Figure tion results in hepatomegaly and splenomegaly, in poly-
clonal B cell activation with selective IgM and IgG1 pro-6B, gate I) and IgMhi (Figure 6B, gate II) cells. Size analy-
sis using forward side-scatter shows that mostly the duction, and in eosinophilia (Johnson et al., 1979). As
shown in Figure 7A, IL-5+/+ mice infected with M. cortilarge IgMhi cells are missing in the IL-52/2 mice. Surpris-
ingly, the reduction of B-1a cells was negligible (0%± developed eosinophilia in the peripheral blood, the bone
marrow, and the peritoneal cavity. The liver of 35-day-20%) in adult (6 to 8 week) IL-52/2 mice (data not shown).
B-1 cells are considered to be the major source of old infected mice was heavily infiltrated with eosinophils
that localized at sites of inflammation and around theIgM serum levels and carriers of natural immunity (Hardy
and Hayakawa, 1994; Kearney et al., 1992; Kocks and worms (Figure 8). In contrast, in IL-52/2 mice the number
of eosinophils in the blood, the bone marrow, and theRajewsky, 1989). Serum immunoglobulin levels of the
various isotypes including IgM, however, werenot differ- peritoneal cavity remained at baseline levels (see Figure
ent in naive 4- and 8-week-old IL-52/2 mice as compared 7A). Consistent with these findings, relatively few eosin-
with controls (data not shown). T-independent B cell ophils accumulated in the livers of IL-52/2 mice (Figure
responses were tested in 6-week-old IL-52/2 mice by 8). Low numbers of eosinophils in the blood and lungs
immunization with the TI-2 antigen TNP±Ficoll. Serum in IL-52/2 mice were also observed after infection with
levels of TNP-specific IgM with k and l light chain ex- the nematode Nippostrongylus brasiliensis (data not
pression was comparable between mutant and con- shown). It is important to note that relatively normal
genic control mice (see Figure 3B). These results sug- steady state levels of eosinophils are produced in IL-5-
gest that IL-5-deficient mice can generate a deficient mice. This is easiest to document in the bone
quantitatively and probably functionally normal B-1 cell marrow (see Figure 7A).
pool, but its appearance is delayed in development. The levels of eosinophils in the IL-52/2 mice are con-
Whether this is due to a redundantly acting cytokine sistently slightly lower (2- to 3-fold) than controls, sug-
warrants investigation. gesting that there is a small contribution by IL-5 to the
regulation of basal eosinophil levels under the condi-
tions in which the mice were housed. However, it isEosinophil Production in IL-5-Deficient Mice
To measure the ability of the IL-52/2 mice to generate a clear that normal eosinophils can be produced in the
complete absence of IL-5, since in IL-5-deficient miceparasite-induced eosinophilia they were infected with
Immunity
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Figure 3. Humoral Immune Response to T-Dependent and Independent Antigens
(A) Mice (5/group) were injected intraperitoneally and subcutaneously with 40 mg of alum-precipitated DNP±ova together with Bordetella
pertussis on days 0 and 14, and bled at indicated times (day 14 after primary and days 7 and 14 after secondary injection). The relative serum
levels of different antibody isotypes specific to DNP±ova were determined by ELISA. Results are expressed as the reciprocal of the serum
dilution where half-maximal absorbance values were obtained.
(B) Mice (5/group) were injected intraperitoneally with 100 mg TNP±Ficoll, and bled at days 0 (d0) and 7 (d7) after injection. Serum levels of
TNP-specific IgM-, k-, and l-bearing antibodies were determined by ELISA. Values are presented as absorbance at OD405nm from groups of
untreated and individual immunized mice.
the eosinophils were morphologically not different from A number of roles for IL-5 have been inferred from
previous studies mainly carried out in vitro. Our initialthose in normal animals when examined by light or elec-
tron microscopy (data not shown). Moreover, the eosin- studies on the IL-5-deficient mice sought to determine
whether there was an obligatory involvement of IL-5 inophils in the IL-5-deficient mice home to sites of parasite
infection, suggesting that they may be functionally nor- these functions in vivo. Together with its activity on
the eosinophil lineage, IL-5 was originally defined by itsmal also. These results indicate that IL-5 is essential for
parasite-induced eosinophilia but not for the steady- activity as a B cell growth factor (Kinashi et al., 1986)
and an IgA enhancing factor (Yokota et al., 1987). IL-5state production of eosinophils.
We also determined the consequences of eosinophilia was also reported to synergize strongly with IL-4 to
promote the development of antibody-secreting cellson the yield of parasites. At day 35 postinfection, the
worm yield in livers and peritoneal cavity from mutant (Mandler et al., 1993). However, we report immunoglob-
ulin levels in both naive and immunized IL-52/2 micemice was comparable to controls (see Figure 7B). This
suggests that eosinophils and IL-5 do not control the were normal, including mucosal IgA responses. The ab-
sence of any apparent difference between wild-type andgrowth or survival or both of M. corti following intraperi-
toneal injection. mutant mice in the latter is notable. Many in vitro studies
have shown that IL-5 promotes IgA responses of acti-Antibody responses (IgM, IgG1, IgG2b, IgG3, IgE, IgA)
to M. corti infection were also measured. The most vated mucosal B cells either alone (Beagley et al., 1988),
or in combination with other factors, such as IL-4 (Mur-marked increases following infection were in IgG1 and
IgE levels but the IL-52/2 mice did not differ from controls ray et al., 1987) and transforming growth factor b (Coff-
man et al., 1989b). In vivo, recombinant IL-5 adminis-in their immunoglobulin levels before or after infection
(data not shown). tered to mice has been shown to enhance mucosal IgA
responses (Pockley and Montgomery, 1991; Ramsay
and Kohonen Corish, 1993). Our data clearly demon-
strate, however, that IL-5 does not play a crucial roleDiscussion
in the normal development of mucosal IgA responses.
Previous reports have suggested that IL-5 also hasThe generation of an IL-5-deficient mouse described in
killer±helper activity (Takatsu et al., 1987), but we wethe present work has provided an important animal
did not find a unique role of IL-5 in the developmentmodel for studying the biological roles of IL-5. IL-5-
deficient mice had no obvious signs of disease and were of antiviral killer cell activity in experiments with either
vaccinia or influenza viruses.fertile.
Phenotype of IL-5-Deficient Mice
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Figure 4. Local Antibody Responses in the Lungs following Infec-
tion with Influenza Virus
Numbers of cells among lung isolates secreting specific antibodies
of the IgA, IgM, IgG1, or IgG2a subclasses were measured by
ELISPOT assay at (A) day 8 and (B) day 15 after infection via the
intranasal route.
A developmental defect in the production of peritoneal
B-1 lymphocytes was detected in IL-5-deficient mice.
Previous studies utilizing in vivo overexpression of IL-
5 either by an IL-5 transgene (Tominaga et al., 1991) or
infection with a retroviral vector carrying IL-5 (Vaux et al.,
1990) suggested that IL-5 can expand the B-1 lineage, a
finding consistent with the demonstration of IL-5 recep-
tors on B-1 cells (Wetzel, 1989) In the IL-52/2 mice, B-1a
cells were reduced by 50%±80% at 2 weeks of age. A
second B-1 cell subset, termed the B-1b sister popula- Figure 5. CTL and NK Responses and Kinetics of Virus Growth in
tion, that is phenotypically similar to B-1a cells, with the Mice Infected with Vaccinia Virus
exception of lack of CD5 expression, appears normal (A) NK activity was measured in vitro at day 3 postinfection against
in IL-52/2 mice. However, this population is difficult to YAC-1 target cells.
(B) Specific CTL activity was measured in vitro at day 6 postinfectionseparate from the conventional CD52 B-2 cells and
against vaccinia-infected MC57G target cells. Responses are ex-therefore was not analyzed in detail. Cell transfer experi-
pressed as the percentage of 51Cr released from labeled target cellsments that are currently being done should help to clarify
as a function of the ratio of effector splenocytes to target cells.
whether only theB-1a or both the B-1a and B-1b popula- (C) Vaccinia virus growth in the ovaries (circles) and lungs (squares)
tion is affected. We do not understand why the numbers are shown as mean geometric titres recovered at day 3, representing
of B-1a cells returned to almost normal in adult (>6 peak growth, and at day 6 postinfection. Most mice have apparently
cleared the virus at the latter timepoint. The broken line representsweeks) mutant mice. This result may indicate that IL-5
the limit of detection of the assay.is required for the early onotogeny but is not required
for their self-renewal. Alternatively, other factors with
an overlapping activity may compensate for theabsence
of IL-5. Recently, IL-10 was reported to be an important
Immunity
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Figure 6. Reduction of CD5+ B Cells (B-1
Cells) in IL-52/2 Mice
Three-color flow cytometric analysis of peri-
toneal exudate cells of 14 days old F2 IL-52/2
(n = 4) and IL-5+/2 littermates (n = 3).
(A) Cells were stained with phycoerythrin-la-
beled anti-CD5, fluorescein isothiocyanate±
labeled anti-IgM, and biotin-labeled anti-
Mac-I (all Dianova) and streptavidin-labeled
RED670 (GIBCO). CD5+IgM+ cells (indicated
by box) from IL-52/2 mice are reduced
(13.4%) compared with their littermate con-
trols (30.9%).
(B) Most remaining CD5+ cells have low IgM
surface expression (box I) and are small in
size, measured by forward side scatter,
whereas CD5+ cells from IL-5+/2 mice have
also IgMhi large cells (box II).
(C) B-1 cells from IL-52/2 mice (indicated by
box) have reduced Mac-I surface expression
compared with control IL5+/2 littermates.
regulator of B-1 lineage development. Anti-IL-10 anti- serum IgM levels and mounted specific IgM responses
body treatment of mice selectively depleted B-1 cells after immunization with TNP±Ficoll, a TI-2 antigen. This
(Ishida et al., 1992). Interestingly, this effect was also result is not unexpected, since almost normal numbers
only transient and was not observed in adult IL-10-defi- of B-1 cells are present in adult mutant mice.
cient mice (Kuhn et al., 1993). In this context, it will be The involvement of IL-5 in regulating eosinophilia during
interesting to analyze B-1 cells in young IL-10-deficient parasite infection (Coffman et al., 1989a) was clearly
mice. The precise role of B-1 cells is still not resolved. verified in the IL-5-deficient mice. The eosinophilia pro-
They are suggested to generate most of the IgM anti- duced in response to infection with M. corti was abol-
body in the serum and tocover responses against bacte- ished in the absence of IL-5. This included a dramatic
rial determinants. IL-52/2 mice had no deficit in natural reduction in the numbers of eosinophils migrating to the
site of parasite infection, as well as the elevation of
eosinophil numbers seen in bone marrow and in the
blood of normal animals. The absence of eosinophiliaTable 1. Reduction in CD51 (B-1) Cells
in the IL-52/2 mice did not affect the worm burden pro-
Experiment Mice Cell number CD51 IgM1 CD52 IgM1
duced by M. corti infection, indicating that eosinophils(3 105) (percent) (percent)
do not control the growth or survival of this parasite
1 IL-52/2 (n 5 2) 6.5 3.8 16.8 following intraperitoneal injection. However, M. corti in-
IL-51/2 (n 5 4) 5.8 20.6 20.5
fection of normal mice is chronic, eventually resulting2 IL-52/2 (n 5 4) 5.0 14.9 22.6
in the death of the mice. It is possible therefore thatIL-51/2 (n 5 3) 6.5 32.3 26
eosinophils play a role in other host±parasite interac-3 IL-52/2 (n 5 4) 8.7 13.4 27.4
IL-51/2 (n 5 3) 8.0 30.9 27.4 tions where the parasite is cleared. Other models need
to be examined to address further the involvement ofPeritoneal exudate cells of 14-day-old IL-52/2 and littermate IL-
eosinophils in host resistance to parasites.51/2 mice were cytofluorometrically analyzed as shown in Figures
2B±2D. In three independent experiments a reduction in CD51 IgM1 Our studies conclusively show that the basal levels
(B-1) cells was found. of morphologically normal eosinophils could be pro-
Phenotype of IL-5-Deficient Mice
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duced in the complete absence of IL-5; suggesting no
obligatory role for IL-5 in the steady-state production
of eosinophils. However, the basal levels of eosinophils
in IL-52/2 animals were consistently 2- to 3-fold lower
than in controls. The eosinophils produced in the IL-
52/2 mice had normal granules and morphology when
examined using electron microscopy (data not shown).
In addition, when immature female IL-52/2 mice were
treated with oestradiol (Tchernitchin et al., 1974) the
residual eosinophils migrated to the uterus with kinetics
analogous to those seen with normal animals (K. I. M.,
unpublished data). The above result raises the possibil-
ity of two subpopulations of eosinophils; one dependent
on IL-5 and another produced by some other mecha-
nism, but investigation of this possibility awaits further
work.
In vitro, IL-3, IL-5, and GM±CSF share biological activi-
ties such as the promotion of eosinophils from hemato-
poietic precursors. This functional redundancy may be
explained by the interaction of their specific binding
receptors with a common b signal transducing receptor.
More recently, mice deficient for the common b chain
of IL-5, IL-3, and GM±CSF receptor (bc2/2 mice) were
reported (Nishinakamura et al., 1995). bc2/2 mice lack
eosinophilia after nematode infection and have a pulmo-
nary disease, which are the characteristic phenotypes
of GM±CSF2/2 mice (Dranoff et al., 1994; Stanley et al.,
1994) and the IL-52/2 mice describedhere. A slight differ-
ence in the reduction of basal numbers of eosinophils
between bc2/2 mice (6- to 8-fold) and IL-52/2 mice (2-
to 3-fold) compared with controls may suggest that GM±
CSF in addition to IL-5 contributes partially to the devel-
opment of eosionphils. However, it should be noted that
the percentage of basal eosinophils (0.5%) did not differ
comparing IL-52/2 and bc2/2 mice. The difference was
found in the control groups (1%±2% in IL-5+/+ mice and
4% in the bc+/+ mice). While this difference could be
attributed to strain differences (inbred C57BL/6 IL-5
mice versus F2[129 3 C57BL/6] bc mice), it may also
indicate IL-5 production in the absence of any obvious
infection in control mice.
In conclusion, the IL-5-deficient mice described in
the present work have provided an unique model to
investigate the role of IL-5 in B cell development and
antibody production as well as the role of eosinophils
in host responses to parasite infection. Furthermore, the
mice will provide the ability to determine the precise
role that IL-5 and eosinophils play in aeroallergen-in-
duced lung damage and hyperreactivity relating to
asthma, as well as their role in other disease models
involving eosinophilia.
Experimental Procedures
Figure 7. Response to Parasite Infestation
The Generation of IL-52/2 Mice
(A) Eosinophils in the peripheral blood, peritoneal cavity, and bone A 1.1 kb XhoI±BamHI fragment of the plasmid pMC1±neopoly(A)
marrow after infection. Blood was collected from the tail vein bi- (Stratagene) containing the neor gene was blunt-end cloned into an
weekly and smears prepared. Cytospin preparations of cells ob- engineered StuI site (targeting the first cysteine codon of exon 3)
tained by peritoneal lavage from 35 day infected mice. Bone marrow contained in a 3.7 kb EcoRI±BamHI fragment of the IL-5 gene. A
cells were obtained from 35 day infected mice by washing the cells
from a single femur from each mouse. The samples were stained
with Giemsa and the number of eosinophils was determined as a
percentage of the total leucocytes. digestion with trypsin. The total number of parasites in each mouse
(B) Parasite replication in infected mice. Tetrathyridia were recov- was determined by counting the worms from the peritoneal cavity
ered from the peritoneal cavity by lavage and from the liver after and from the liver digests under a dissecting microscope.
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Figure 8. Histological Appearance of the Livers of M. corti Infected Mice
The sections show inflammatory lesions around the worms in the liver (top, original magnification, 3003) of IL-5+/+ mice (left) and IL-52/2 mice
(right) with a massive infiltration of eosinophils in IL-5+/+ but very few eosinophils IL-52/2 mice (bottom, original magnification, 12003). Infected
mice were sacrificed after 35 days and the livers prepared for light microscopy by standard formalin/paraffin procedures and stained with
Giemsa.
2.8 kb EcoRI±HindIII fragment of the HSV±tk cassette was then GCT TCC AAG GTG CTT CGC-39 (reverse): and for IL-3 they were
from Stratagene, number 302113.blunt-end cloned into the BamHI site of the IL-5 gene fragment in
the plasmid pTZ19u. The vector was linearized with XmnI before
electroporation into C57BL/6 ES cells (Ledermann and Burki, 1991).
Positive±negative selection (Mansour et al., 1988) was used to enrich Cytokine Analysis
Cell culture supernates were obtained as described as above. Anfor homologous recombinants, which were identified by PCR analy-
sis with nested primers IL-5±P1/P2 and neo±P1/P2 (Figure 1) IL-2 bioassay was performed as described (Mosmann, 1983) using
the cell line HT-2. IL-3, IL-4, IL-5, IL-10, and IFNg protein levels were(Nitschke et al., 1993). Verification of the targeting of the IL-5 allele
was determined by Southern blot analysis of genomic DNA from ES determined by ELISA using monoclonal antibodies prepared from
hybridomas supplied by Dr. J. Abrams and Dr. T. Mosman (DNAXcells restricted with SacI or BglII±StuI and probed with the IL-5
cDNA (data not shown). All targeted ES cell clones were probed for Research Institute). Supernates from wells not coated with anti-CD3
contained no detectable cytokines.the integration of only one neor gene with pMC1±neopoly(A) (data
not shown).
RT±PCR Analysis B Cell Responses after Immunization
For T-dependent B cell responses groups of mice (2±3 months old,B cell± and red cell±depleted spleen cells (1 3 105/well) of IL-5+/+
and IL-52/2 mice were stimulated in anti-CD3 (34 mg/ml) coated n = 5) were immunized intraperitoneally and subcutaneously with
40 mg DNP±ova precipitated in alum (Serva) together with 2 3 108wells in the presence of recombinant murine IL-4 (100 U/ml) for 4
days, washed and cultured for a further 2 days in medium containing Bordetella pertussis (Behring) at day 0 and boosted after 14 days.
Serum was taken at day 14 after primary and at day 7 and 14 afterIL-2 (60 U/ml), and then restimulated for 16 hr in anti-CD3-coated
wells together with anti-CD28 (5 mg/ml). Finally, the cells were pel- secondary immunization. Relative serum titres of different antibody
isotypes (IgM, IgG1, IgG2b) specific to DNP±ova were determinedleted for RNA extraction (RNAzolTMB, Cinna/Biotec) and the super-
natants were used for cytokine analysis. The RNA was dissolved in by ELISA using DNP±ova-coated (50 mg/ml) plates. Alkaline phos-
phatase±labeled goat anti-mouse (gam)±IgM, gam±IgG1, gam±10 ml DEPC-treated water and reverse transcribed (MMLV reverse
transcriptase, BRL) with oligo-dT as primer in a total volume of 20 IgG2b (all Southern Biotechnology Associates) were used for de-
tection.ml using standard conditions. The cDNA was diluted 1:10 and 2 ml
of this used in 35 cycles of PCR in a total volume of 20 ml in a For T-independent B cell responses, groups of mice (6 weeks old,
n = 5) were immunized intraperitoneally with 100 mg TNP±Ficoll.capillary cycle sequencer (Corbett Research, Australia) with 0.25 U
SUPER TAQ (Stehelin AG, Switzerland). PCR primers for IL-5 cDNA Mice were bled before and at day 7 after immunization. Levels of
anti TNP-specific IgM, k, and l light chains were determined bywere 59-TTG ACA AGC AAT GAG ACG ATG AG-39 (forward), and
59-ACC AGT TTG AGG CCA GCC TGC G-39 (reverse); for IL-4 they ELISA. Plates (Nunc Polysorb) were coated with TNP±bovine serum
albumin (50 mg/ml) and bound immunoglobulin of diluted serumwere 59-GAA TGT ACC AGG AGC CAT ATC-39 (forward) and 59-AGG
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